Treatment of post-transplanted, relapsed patients with hematological malignancies by infusion of HLA-matched, allogeneic-dendritic cells (DCs) pulsed with irradiated tumor cells and primed T cells

Leukemia and Lymphoma

Volumn 42, Issue 3, 2001, Pages 357-369

  Fujii, S I ^a   Shimizu, K ^a   Fujimoto, K ^a   Kiyokawa, T ^a   Tsukamoto, A ^a   Sanada, I ^a   Kawano, F ^a  

^a NATIONAL HOSPITAL ORGANIZATION KUMAMOTO MEDICAL CENTER   (Japan)

Author keywords

Allogeneic peripheral blood stem cell transplantation; Cytotoxic T cell; Dendritic cell; Donor lymphocyte infusion

Indexed keywords

ANTIGEN; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 4; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ADULT; ALLOGRAFT; ARTICLE; BONE MARROW TRANSPLANTATION; CANCER IMMUNOTHERAPY; CANCER RECURRENCE; CASE REPORT; CELL FUNCTION; CELL MATURATION; CELL MOTILITY; CELL SPECIFICITY; CELL STRUCTURE; CELL TRANSPLANTATION; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; DONOR; FEMALE; GRAFT VERSUS HOST REACTION; HEMATOLOGIC DISEASE; HLA MATCHING; HUMAN; IN VITRO STUDY; INCUBATION TIME; INFUSION; IRRADIATION; LYMPHOCYTE TRANSFUSION; MALE; PERIPHERAL BLOOD STEM CELL; PHENOTYPE; PRIORITY JOURNAL; T LYMPHOCYTE; TUMOR CELL;

EID: 0034904675     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428190109064592     Document Type: Article

References (27)

1. Donor leukocyte infusion for relapse in chronic myelogenous leukaemia
2. Induction of graft-versus-host disease as immunotherapy for relapsed chronic myeloid leukaemia
3. Dendritic cells and the control of immunity
4. Dendritic cells: Unique leukocyte populations which control the primary immune response
5. Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells
6. Tumor-specific idiotype vaccines in the treatment of patients with B-cell lymphoma-long-term results of a clinical trial
7. Tumor-specific, cytotoxic T-lymphocyte response after idiotype vaccination for B-cell, non-Hodgkin's lymphoma
8. Vaccination of melanoma patients with peptide- or tumour lysate-pulsed dendritic cells
9. + cord blood cell-derived and irradiated tumour cell-primed dendritic cells
10. + hematopoietic progenitor cells: Induction of autologous cytotoxic T lymphocytes against leukemic cells in acute myelogenous leukemia patients
11. Activated dendritic cells from bone marrow cells of mice receiving cytokine-expressing tumor cells are associated with the enhanced survival of mice
12. Lactate dehydrogenase-release assay: A reliable, nonradioactive technique for analysis of cytotoxic lymphocyte-mediated lytic activity against blasts from acute myelocytic leukaemia
13. Direct demonstration of cytokine synthesis heterogeneity among human memory/effector T cells by flow cytometry
14. Analysis of a chronic myelogenous leukemia patient vaccinated with leukemic dendritic cells following autologous peripheral blood stem cell transplantation
15. + blood progenitors for anticancer therapy
16. + peripheral blood progenitor cell and monocyte derived dendritic cells: A comparative analysis
17. Generation of virtually pure and potentially proliferating dendritic cells from non-CD34 apheresis cells from patients with multiple myeloma
18. + cell-depleted mobilised peripheral blood can serve as a source of potent dendritic cells
19. Allogeneic peripheral blood progenitor cell transplantation in murine model: Evidence for an improved graft-versus-leukaemia effect
20. Graft-versus-host-disease as adoptive immunotherapy in patients with advanced hematologic neoplasms
21. The immunobiology of T cell therapies for leukemias
22. T cell-depleted allogeneic bone marrow transplantation in adults with acute nonlymphocytic leukemia in first remission
23. T cell-depleted allogeneic bone marrow transplantation as post-remission therapy for acute myelogeneous leukemia: Freedom from relapse in the absence of graft-versus-host disease
24. T-cell depletion of HLA-identical transplants in leukemia
25. Graft-versus-leukemia effect of donor lymphocyte transfusion in marrow grafted patients
26. Chemotherapy and donor peripheral blood progenitor cells for acute leukemia in early relapse after allogeneic bone marrow transplantation
27. Engraftment kinetics after non-myeloablative allogeneic peripheral blood stem cell transplantation: Full donor T-cell chimerism precedes alloimmune responses